Navigation Links
Genmab Announces Results for the First Nine Months of 2007
Date:10/30/2007

ne head and neck cancer in cooperation with the Danish Head and Neck Cancer Group (DAHANCA).

An asset exchange agreement with Medarex to gain all rights to HuMax-Inflam(TM), now known as HuMax-IL8(TM). Genmab plans to develop the antibody for the treatment of glioblastoma, a cancer of the central nervous system.

Amending a pivotal study of HuMax-CD20(R) (ofatumumab) to treat non-hodgkin's lymphoma from two arms to a single arm study.

Outlook

Genmab is maintaining its financial guidance for the year. We expect our revenues to benefit from the achievement of certain development milestones in the fourth quarter of 2007 and we continue to project a 2007 operating loss of DKK 385 to 435 million and a net loss in the range of DKK 260 to 310 million.

Genmab's projected December 31, 2007 cash position is expected to be in the range of DKK 3.8 to 3.9 billion.

Conference Call

Genmab will hold a conference call to discuss the results for the nine month period ended September 30, 2007 tomorrow, Wednesday, October 31, 2007, at

2.00 pm CET 1.00 pm GMT 9.00 am EDT

The conference call will be held in English.

The dial in numbers are as follows:

+1-800-231-9012 (in the US) and ask for the Genmab conference call +1-719-457-2706 (outside the US) and ask for the Genmab conference call

A live webcast of the call and relevant slides will be available at http://www.genmab.com. The webcast will also be archived on Genmab's website.

About Genmab A/S

Genmab is a leading international biotechnology company focused on developing fully human antibody therapeutics for unmet medical needs. Using unique, cutting-edge antibody technology, Genmab's world class discovery and development teams have created and developed an extensive pipeline of products for potential treatment of a variety of diseases including cancer and autoimmune disorders.

As Genmab advances t
'/>"/>

SOURCE Genmab A/S
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. Speaker announces business members of IT Task Force
2. Doyle announces technology tax credits for Berbee
3. Doyle announces new energy, global warming policies
4. Doyle announces $80M renewable energy strategy
5. GE announces first installation of Discovery VCT
6. UWM announces winners of RGI awards
7. Third Wave announces two senior management appointments
8. Mirus announces new method for making antibodies
9. Merge announces sofware updates, upcoming acquisition
10. Small Tree announces ethernet solution for Apple Xserv G5
11. TEKLYNX International announces new RFID software
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2008)...Belfast is to become the United Kingdom,s lead cen...ious ,cyber-attacks, after a funding boost from th...il. , Almost 7m from the EPSRC will help fund a...for Secure Information Technologies (CSIT) - which..., Communications and Information Technology (ECIT)...
(Date:11/20/2008)... Nov. 20 Par Pharmaceuti... that the U.S. District Court for the District of ...uticals, motion for a temporary restraining order ...spules(R) (budesonide inhaled solution). In conju...eneca agreed and that it too would halt all sales ...
(Date:11/20/2008)...RNewswire-FirstCall/ -- Sigma-Aldrich (Nasdaq: S...ON(R) In VIVO QUALITY and iScale,Oligos(TM) siRNA... siRNA are,expected to allow researchers to succe... with the highest purity and quality siRNA require... are believed to be well suited to target,validat...
(Date:11/20/2008)... KansasBio announced today a,bios...e region,s human,health-care-related bioscience c...ontinuum. Called the National Drug Development Acc...s companies across Kansas and the Kansas,City met... preferred resources,for drug development. , ...
Breaking Biology Technology:Queen's 'secures' £25m for UK's cyber-safety 2Par Pharmaceutical Halts Shipment of Budesonide Inhalation Suspension 2Sigma-Aldrich Introduces MISSION(R) In VIVO QUALITY and iScale Oligos(TM) siRNA, a Superior Quality siRNA Designed for RNAi Research in Animal Models 2National Drug Development Accelerator Launched 2
... and CEO of ZyStor Therapeutics, Inc. is looking...ttendees of this year,s Midwestern bioscience foru...ill represent Wisconsin biotechnology companies wi...Madison-based EraGen Biosciences , a developer of...e attendees, Peterson is interested in the network...
...tartup biotechnology firm with laboratories in Mil...the gap between molecular and animal testing metho...disorders, and other maladies, Invivo,s manufactur... ,Using tissues derived from neonatal rats, the co...nsin Biotechnology and Medical Device Association ...
...consin research team has received a five-year, $1... pressure. , ,The grant was provided by the Natio...the impact that genes within specific regions of c...ssure and kidney failure. According to the institu...n, affects one in three American adults. , ,The Me...
... University of Wisconsin-Madison stimulates the l...anies. But a new study has produced figures to bac...sed in the University Research Park , located thr...ased on university research. And the concentration..., has had a significant impact on the surrounding ...
Other Biology Technology:ZyStor to exhibit cell disorder treatments 2Biotech firm uses live heart tissue in drug screens 2Biotech firm uses live heart tissue in drug screens 3Medical College receives $11 million grant to study high blood pressure 2Impact of research park firms pegged at $680M 2
(Date:11/21/2008)...rdiovascular conditions leading to heart attacks a...n cancers of the prostate, breast or lung, but now...hanisms at the molecular level. This in turn provi...cer and cardiovascular diseases, but requires rese... The seeds were sown for closer cooperation betwee...
(Date:11/20/2008)...SHINGTON, DC Although Americans are becoming incr...ryday household products like bisphenol A in some ...eadily connect typical household products with per... effects, according to research from the December ...r . , "People more readily equate pollution wit...
(Date:11/20/2008)...TTSBURGHResearch from the University of Pittsburgh...uld finally provide evidence of the first stages o...olds that males and females developed from hermaph...letely understood because the majority of animal s...g separate-sex state too long ago for scientists t...
(Date:11/20/2008)...his release is available in German . , Hal... get a comprehensive overview of which alien speci...uences for the environment and society. More than ...E (Delivering Alien Invasive Species Inventory for...h more than 100 European scientists, funded by the...
Breaking Biology News(10 mins):Mechanisms of cardiovascular disease and cancer give clues to new therapies 2Mechanisms of cardiovascular disease and cancer give clues to new therapies 3Pollution at home lurks unrecognized, instead attributed to large-scale environmental disasters 2Two from one: Pitt research maps out evolution of genders from hermaphroditic ancestors 211,000 alien species invade Europe 2NIH funded Vanderbilt Research Seeks Ways to Avoid Information Overload in Health Care Choices Among Seniors 13533 1NIH funded Vanderbilt Research Seeks Ways to Avoid Information Overload in Health Care Choices Among Seniors 13533 2Cultivating the Smart Patient 3A Author and RealAge Founder Michael F Roizen MD to Present Keynote at URAC Conference 13528 1Cultivating the Smart Patient 3A Author and RealAge Founder Michael F Roizen MD to Present Keynote at URAC Conference 13528 2Cultivating the Smart Patient 3A Author and RealAge Founder Michael F Roizen MD to Present Keynote at URAC Conference 13528 3Smith 26 Nephew Endoscopys BIORAPTOR 28TM 29 2 3 PK Suture Anchor Provides Secure Repair for Shoulder Hip Instability 13524 1Smith 26 Nephew Endoscopys BIORAPTOR 28TM 29 2 3 PK Suture Anchor Provides Secure Repair for Shoulder Hip Instability 13524 2Smith 26 Nephew Endoscopys BIORAPTOR 28TM 29 2 3 PK Suture Anchor Provides Secure Repair for Shoulder Hip Instability 13524 3Smith 26 Nephew Endoscopys BIORAPTOR 28TM 29 2 3 PK Suture Anchor Provides Secure Repair for Shoulder Hip Instability 13524 4New Books on Best Practices in Biotechnology Business Development and Biotechnology Education 3730 1New Books on Best Practices in Biotechnology Business Development and Biotechnology Education 3730 2
...s of directional cues to guide their seasonal migr...h,s magnetic field, and sky polarized light patter...ty changes with time of day and weather conditions...common reference. Experiments over the last 30 yea... of how migratory birds integrate multiple sources...
...en,s Research Hospital have announced that a vacci...genic variant of the avian influenza virus H5N1 ma...rus. Vaccines based on this model might therefore ...mic (worldwide epidemic) until a new vaccine could...sing the outbreak, the researchers said. An antige...
... last several months, the labs of Yale Goldman, MD...te at the University of Pennsylvania School of Med...ology, have published a group of papers that, take...ar motors are surprisingly flexible and agile, abl...ervations could lead to better ways to treat motor...
...lifetime of daily injections to replace the insuli...of risks that includes blindness, amputation, kidn...rly those afflicted with juvenile diabetes, transp... produced might alleviate these problems. Unfortun...ailable for transplantation. , Insulin-producing p...
Other Biology News:Light guides flight of migratory birds 2Light guides flight of migratory birds 3H5N1 vaccine could be basis for life-saving stockpile 2Discovery of agile molecular motors could aid in treating motor neuron diseases 2Successful transplantation from pig embryos to mice 2